Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity
Open Access
Abstract
CIGB-552 is a twenty-amino-acid novel synthetic peptide that has proven to be effective in reducing tumor size and increasing lifespan in tumor-bearing mice. Such capability is conferred by its cell-penetrating peptide character, which allows it to enter cells and elicit a pro-apoptotic effect through its major mediator, COMMD1 protein. Cell-penetrating peptides are able to use different internalization mechanisms, such as endocytosis or direct transduction through the plasma membrane. Although CIGB-552 cytotoxicity has been evaluated in several non-tumor- and tumor-derived cell lines, no data regarding the relationship between cell line sensitivity, cell penetrating capacity, the internalization mechanisms involved, COMMD1 expression levels, or its subcellular localization has yet been produced. Here, we present the results obtained from a comparative analysis of CIGB-552 sensitivity, internalization capacity and the mechanisms involved in three human tumor-derived cell lines from different origins: mammary gland, colon and lung (MCF-7, HT-29 and H460, respectively). Furthermore, cell surface markers relevant for internalization processes such as phosphatidylserine, as well as CIGB-552 target COMMD1 expression/localization, were also evaluated. We found that both endocytosis and transduction are involved in CIGB-552 internalization in the three cell lines evaluated. However, CIGB-552 incorporation efficiency and contribution of each mechanism is cell-line dependent. Finally, sensitivity was directly correlated with high internalization capacity in those cell lines where endocytosis had a major contribution on CIGB-552 internalization.Keywords
Funding Information
- FOCEM (COF 03/11)
- Agencia Nacional de Investigación e Innovación (POS_NAC_2012_1_8523)
This publication has 30 references indexed in Scilit:
- Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552Journal of Peptide Science, 2016
- Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB‐552 in mouse modelsJournal of Peptide Science, 2014
- Tuning NF-κB activity: A touch of COMMD proteinsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Cell‐penetrating peptides: 20 years later, where do we stand?FEBS Letters, 2013
- The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer CellsJournal of Amino Acids, 2013
- Cell-penetrating peptides: classes, origin, and current landscapeDrug Discovery Today, 2012
- Mechanisms of Cellular Uptake of Cell-Penetrating PeptidesJournal of Biophysics, 2011
- Identification of a novel antitumor peptide based on the screening of an Ala‐library derived from the LALF32–51 regionJournal of Peptide Science, 2009
- Cell Entry of Arginine-rich Peptides Is Independent of EndocytosisJournal of Biological Chemistry, 2009
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008